DSTU2 QA Preview

This page is part of the FHIR Specification (v1.0.0: DSTU 2 Ballot 3). The current version which supercedes this version is 5.0.0. For a full list of available versions, see the Directory of published versions . Page versions: R5 R4B R4 R3 R2

Valueset-allergy-intolerance-type.json

Raw JSON (canonical form)

Definition for Value SetAllergyIntoleranceType

{
  "resourceType": "ValueSet",
  "id": "allergy-intolerance-type",
  "meta": {
    "lastUpdated": "2015-09-01T14:38:48.206+10:00",
    "profile": [
      "http://hl7.org/fhir/StructureDefinition/valueset-shareable-definition"
    ]
  },
  "text": {
    "status": "generated",
    "div": "<div>!-- Snipped for Brevity --></div>"
  },
  "extension": [
    {
      "url": "http://hl7.org/fhir/StructureDefinition/valueset-oid",
      "valueUri": "urn:oid:2.16.840.1.113883.4.642.2.52"
    }
  ],
  "url": "http://hl7.org/fhir/ValueSet/allergy-intolerance-type",
  "version": "1.0.0",
  "name": "AllergyIntoleranceType",
  "status": "draft",
  "experimental": false,
  "publisher": "HL7 (FHIR Project)",
  "contact": [
    {
      "telecom": [
        {
          "system": "other",
          "value": "http://hl7.org/fhir"
        },
        {
          "system": "email",
          "value": "fhir@lists.hl7.org"
        }
      ]
    }
  ],
  "date": "2015-09-01T14:38:48+10:00",
  "description": "Identification of the underlying physiological mechanism for a Reaction Risk",
  "codeSystem": {
    "extension": [
      {
        "url": "http://hl7.org/fhir/StructureDefinition/valueset-oid",
        "valueUri": "urn:oid:2.16.840.1.113883.4.642.1.52"
      }
    ],
    "system": "http://hl7.org/fhir/allergy-intolerance-type",
    "version": "1.0.0",
    "caseSensitive": true,
    "concept": [
      {
        "code": "allergy",
        "display": "Allergy",
        "definition": "Immune-mediated hypersensitivity reaction."
      },
      {
        "code": "intolerance",
        "display": "Intolerance",
        "definition": "Adverse reaction to a substance, not judged to be immune-mediated (non-allergic).  This can include (but is not limited to) pseudoallergic reactions, side effects, drug toxicities (eg to Gentamicin), drug-drug interactions, food-drug interactions, and drug-disease interactions."
      }
    ]
  }
}

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.